组织型纤溶酶原激活剂成功治疗中脑周围非动脉瘤性蛛网膜下腔出血患者的鞍状肺栓塞
本文报告一例48岁男性中脑周围非动脉瘤性蛛网膜下腔出血(PNSH)患者,在出血后第8天因鞍状肺栓塞导致梗阻性休克及无脉电活动,接受全身组织型纤溶酶原激活剂(tPA)治疗,未发生再出血,最终安全出院至康复机构。作者认为,鉴于PNSH良性自然史,tPA可能是安全的干预措施,且该案例不支持血栓性破裂微动脉瘤理论。
要点
- PNSH患者发生危及生命的肺栓塞时,全身tPA可能安全使用。
- 本例tPA使用后未出现颅内再出血。
- 该观察结果不支持PNSH源于血栓性破裂微动脉瘤的理论。
核心结论
- 在PNSH背景下,因鞍状肺栓塞导致梗阻性休克时使用全身tPA未导致再出血,提示tPA可能是安全的干预措施。
研究设计与样本
- 病例报告:一名48岁男性PNSH患者,因多发性静脉血栓栓塞长期服用阿哌沙班。
主要发现
- 患者表现为突发剧烈头痛、视物模糊、恶心及颈强直,CT示中脑周围出血模式(Hunt and Hess 2级,Fisher 3级)。
- CT血管造影及6血管数字减影血管造影未发现出血原因。
- 出血后第8天因鞍状肺栓塞致梗阻性休克及无脉电活动,给予全身tPA。
- 患者未发生再出血,安全出院至康复机构,遗留与心脏骤停缺血效应相关的中度神经功能缺损。
临床怎么用
- 神经重症医生和神经外科医生应知晓,在PNSH背景下,静脉tPA可用于危及生命的肺栓塞。
局限性
- 本文为单例病例报告,证据级别有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Perimesencephalic nonaneurysmal subarachnoid hemorrhage (PNSH) is characterized by a typical pattern of localized pretruncal hemorrhage on head computed tomography. PNSH is usually associated with a benign clinical course and a lower incidence of complications. The etiology is unknown, but many explanations have been proposed, including venous injury or rupture followed by thrombosis of a ruptured microaneurysm. CASE DESCRIPTION: A 48-year-old man on apixaban for multiple venous thromboembolisms presented with the worst headache of his life associated with blurry vision, nausea, and neck stiffness. Computed tomography demonstrated a perimesencephalic pattern of blood (Hunt and Hess grade 2, Fisher grade 3). Computed tomography angiography and 6-vessel digital subtraction angiography demonstrated no precipitating cause. Systemic tissue plasminogen activator (tPA) was administered on postbleed day 8 owing to obstructive shock from saddle pulmonary embolism and pulseless electrical activity. He was safely discharged to rehabilitation with moderate neurological deficits attributed to ischemic effects of his cardiac arrest. CONCLUSIONS: Symptomatic saddle pulmonary embolism in the setting of intracranial hemorrhage creates conflicting risks of medical intervention. There are no case reports or evidence of the use of systemic thrombolysis in the setting of SAH. Owing to the benign natural history of PNSH, tPA may be a safe intervention. Neurointensivists and neurosurgeons should be aware that intravenous tPA was used safely for life-threatening pulmonary embolism in the setting of PNSH. Additionally, the use of tPA without resultant rebleeding in this case opposes the theory of the presence of a thrombosed ruptured microaneurysm.
引用
- Porche K, Robinson C, Polifka A, et al. Successful Use of Tissue Plasminogen Activator for Saddle Pulmonary Embolism in Perimesencephalic Nonaneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2020. PMID: 32971282. doi:10.1016/j.wneu.2020.09.089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。